A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (21)

10676

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 212929, Athens

11526

Henry Dunnant Hospital Center /ID# 241682, Athens

11527

General Hospital of Athens Gennimatas /ID# 212917, Athens

General Hospital of Athens Laiko /ID# 212902, Athens

General Hospital of Athens Laiko /ID# 230222, Athens

12462

University General Hospital Attikon /ID# 212915, Athens

15125

Iatriko Kentro Athinon /ID# 241689, Marousi

Iatriko Kentro Athinon /ID# 241690, Marousi

15562

Metropolitan General /ID# 212934, Cholargós

18547

Metropolitan Hospital /ID# 241687, Piraeus

18737

METAXA Cancer Hospital of Piraeus /ID# 212918, Piraeus

26335

General Hospital of Patras Agios Andreas /ID# 213711, Pátrai

26504

University Gen Hosp of Patra /ID# 212914, Pátrai

41110

Reg Gen Univ Hosp Larissa /ID# 213708, Larissa

45500

University General Hospital of Ioannina /ID# 212936, Ioannina

54639

Theageneio Anticancer Hospital /ID# 212933, Thessaloniki

56429

Papageorgiou General Hospital /ID# 213710, Thessaloniki

57010

General Hospital of Thessaloniki George Papanikolaou /ID# 213709, Thessaloniki

68100

General University Hospital of Alexandroupolis /ID# 212927, Alexandroupoli

71500

University General Hospital of Heraklion PA.G.N.I /ID# 212916, Heraklion

73300

"General Hospital of Chania Agios Georgios /ID# 241685", Chania

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY